Literature DB >> 26722270

Interpretation of a heterogeneous radiological response as tumor heterogeneity or a non-tumor diagnosis: A case report.

Jeong-Seon Ryu1, Lucia Kim2, Woo Chul Kim3, Jung-Soo Kim1, Azra Memon1, Bo-Rim Yi1, Hyun-Jung Kim1.   

Abstract

Heterogeneous radiological responses (HRRs) among tumor lesions are usually observed following chemotherapy or radiation treatment in cancer patients. When HRR is observed after chemotherapy or radiation treatment, a change in anticancer treatment is recommended due to the clinically high suspicion of resistance in the majority of cases. The present study reports the case report of a patient with limited-stage small cell lung cancer, diagnosed by bronchoscopy, who received concurrent chemoradiation therapy. Upon response evaluation, the majority of lesions irradiated had nearly completely disappeared following treatment, but one lesion had apparently increased in size. For histological confirmation, a percutaneous needle biopsy for the lesion was performed, however, non-specific necrosis was found and the results were inconclusive for the differentiation of other causes from tumor necrosis. Several acid-fast bacilli were identified on Ziehl-Neelsen staining for the differential diagnosis. This case suggests that a non-tumor diagnosis should be considered when HRR presents after treatment that is expected to result in a higher response rate, particularly in tuberculosis endemic areas.

Entities:  

Keywords:  small cell lung cancer; tuberculosis; tumor heterogeneity

Year:  2015        PMID: 26722270      PMCID: PMC4665751          DOI: 10.3892/ol.2015.3709

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study.

Authors:  C-Y Wu; H-Y Hu; C-Y Pu; N Huang; H-C Shen; C-P Li; Y-J Chou
Journal:  Int J Tuberc Lung Dis       Date:  2011-01       Impact factor: 2.373

2.  Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.

Authors:  Thida Win; Kenneth A Miles; Sam M Janes; Balaji Ganeshan; Manu Shastry; Raymondo Endozo; Marie Meagher; Robert I Shortman; Simon Wan; Irfan Kayani; Peter J Ell; Ashley M Groves
Journal:  Clin Cancer Res       Date:  2013-05-09       Impact factor: 12.531

3.  A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients.

Authors:  J A Stratton; P E Byfield; J E Byfield; R C Small; J Benfield; Y Pilch
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

4.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

5.  Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.

Authors:  Kazumasa Noda; Yutaka Nishiwaki; Masaaki Kawahara; Shunichi Negoro; Takahiko Sugiura; Akira Yokoyama; Masahiro Fukuoka; Kiyoshi Mori; Koshiro Watanabe; Tomohide Tamura; Seiichiro Yamamoto; Nagahiro Saijo
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

6.  Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress.

Authors:  J P Chute; T Chen; E Feigal; R Simon; B E Johnson
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

7.  The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.

Authors:  Frances A Shepherd; John Crowley; Paul Van Houtte; Pieter E Postmus; Desmond Carney; Kari Chansky; Zeba Shaikh; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-12       Impact factor: 15.609

8.  The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Eric Vallières; Frances A Shepherd; John Crowley; Paul Van Houtte; Pieter E Postmus; Desmond Carney; Kari Chansky; Zeba Shaikh; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-09       Impact factor: 15.609

9.  Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases.

Authors:  C S van Kessel; M Samim; M Koopman; M A A J van den Bosch; I H M Borel Rinkes; C J A Punt; R van Hillegersberg
Journal:  Eur J Cancer       Date:  2013-05-18       Impact factor: 9.162

10.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.